Testing a Diathesis-Stress Model: Potential Genetic Risk Factors for Development of Distress in Context of Acute Leukemia Diagnosis and Transplant

Psychosomatics

Volumn 53, Issue 5, 2012, Pages 456-462

  Romanowicz, Magdalena ^a   Ehlers, Shawna ^b   Walker, Denise ^b   Decker, Paul ^b   Rundell, James ^d   Shinozaki, Gen ^c   Litzow, Mark ^b   Hogan, William ^b   Mrazek, David ^b   Black, John L ^b  

^a STANFORD UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRHR1 PROTEIN; FKBP5 PROTEIN; MEMBRANE PROTEIN; METHIONINE; STAT PROTEIN; STIN2 PROTEIN; UNCLASSIFIED DRUG; VALINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; FK 506 BINDING PROTEIN; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN; TACROLIMUS BINDING PROTEIN 5;

ACUTE LEUKEMIA; ADJUSTMENT DISORDER; ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DIATHESIS STRESS MODEL; DISEASE ASSOCIATION; DISTRESS SYNDROME; FEMALE; GENETIC RISK; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HUMAN; HYPOTHESIS; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL HEALTH; MODEL; RETROSPECTIVE STUDY; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LEUKEMIA; MENTAL STRESS; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADJUSTMENT DISORDERS; ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; COHORT STUDIES; DEPRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RETROSPECTIVE STUDIES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRESS, PSYCHOLOGICAL; TACROLIMUS BINDING PROTEINS;

EID: 84873021528     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2012.01.004     Document Type: Article

References (37)

1. Battersby S., Ogilvie A.D., Smith C.A., Blackwood D.H., Muir W.J., Quinn J.P., et al. Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatr Genet 1996, 6:177-181.
2. Borroni B., Archetti S., Costanzi C., Grassi M., Ferrari M., Radeghieri A., et al. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. Neurobiol Aging 2009, 30:1406-1412.
3. Borroni B., Grassi M., Archetti S., Costanzi C., Bianchi M., Caimi L., et al. BDNF genetic variations increase the risk of Alzheimer's disease-related depression. J Alzheimers Dis 2009, 18:867-1875.
4. Bradley R.G., Binder E.B., Epstein M.P., Tang Y., Nair H.P., Liu W., et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 2008, 65:190-200.
5. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
6. Ramasubbu R., Tobias R., Buchan A.M., Bech-Hansen N.T. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression. J Neuropsychiatry Clin Neurosci 2006, 18:96-99.
7. Frodl T., Schule C., Schmitt G., Born C., Baghai T., Zill P., et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 2007, 64:410-416.
8. Montag C., Weber B., Fliessbach K., Elger C., Reuter M. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Psychol Med 2009, 39:1831-1839.
9. Kaufman J., Yang B.Z., Douglas-Palumberi H., Houshyar S., Lipschitz D., Krystal J.H., et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci USA 2004, 101:17316-17321.
10. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005, 62:529-535.
11. Lenze E.J., Munin M.C., Ferrell R.E., Pollock B.G., Skidmore E., Lotrich F., et al. Association of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) genotype with depression in elderly persons after hip fracture. Am J Geriatr Psychiatry 2005, 13:428-432.
12. Licinio J., Dong C., Wong M.L. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch Gen Psychiatry 2009, 66:488-497.
13. Nakatani D., Sato H., Sakata Y., Shiotani I., Kinjo K., Mizuno H., et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005, 150:652-658.
14. Murphy K.C., Jenkins P.L., Whittaker J.A. Psychosocial morbidity and survival in adult bone marrow transplant recipients-a follow-up study. Bone Marrow Transplant 1996, 18:199-201.
15. Khan A.G., Irfan M., Shamsi T.S., Hussain M. Psychiatric disorders in bone marrow transplant patients. J Coll Physicians Surg Pak 2007, 17:98-100.
16. Molassiotis A., van den Akker O.B., Milligan D.W., Goldman J.M., Boughton B.J., Holmes J.A., et al. Quality of life in long-term survivors of marrow transplantation: comparison with a matched group receiving maintenance chemotherapy. Bone Marrow Transplant 1996, 17:249-258.
17. Sasaki T., Akaho R., Sakamaki H., Akiyama H., Yoshino M., Hagiya K., et al. Mental disturbances during isolation in bone marrow transplant patients with leukemia. Bone Marrow Transplant 2000, 25:315-318.
18. Illescas-Rico R., Amaya-Ayala F., Jimenez-Lopez J.L., Caballero-Mendez M.E., Gonzalez-Llaven J. Increased incidence of anxiety and depression during bone marrow transplantation. Arch Med Res 2002, 33:144-147.
19. Karg K., Burmeister M., Shedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011, 68(5):444-454.
20. Ahles T.A., Tope D.M., Furstenberg C., Hann D., Mills L. Psychological and neuropsychological impact of autologous bone marrow transplantation. J Clin Oncol 1996, 14:1457-1462.
21. Andrykowski M.A., Henslee P.J., Barnett R.L. Longitudinal assessment of psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1989, 4:505-509.
22. Colon E.A., Callies A.L., Popkin M.K., McGlave P.B. Depressed mood and other variables related to bone marrow transplantation survival in acute leukemia. Psychosomatics 1991, 32:420-425.
23. Cattaneo A., Bocchio-Chiavetto L., Zanardini R., Marchina E., Bellotti D., Milanesi E., et al. BDNF Val66Met polymorphism and protein levels in amniotic fluid. BMC Neurosci 2010, 11:16.
24. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
25. Chen Z.Y., Patel P.D., Sant G., Meng C.X., Teng K.K., Hempstead B.L., et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004, 24:4401-4411.
26. Chiaruttini C., Vicario A., Li Z., Baj G., Braiuca P., Wu Y., et al. Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation. Proc Natl Acad Sci USA 2009, 106:16481-16486.
27. Echeverria D., Woods J.S., Heyer N.J., Rohlman D.S., Farin F.M., Bittner A.C., et al. Chronic low-level mercury exposure, BDNF polymorphism, and associations with cognitive and motor function. Neurotoxicol Teratol 2005, 27:781-796.
28. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Putz B., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004, 36:1319-1325.
29. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005, 62(5):529-535.
30. Wendland J.R., Martin B.J., Kruse M.R., Lesch K.P., Murphy D.L. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol. Psychiatry 2006, 11(3):224-226.
31. Battersby S., Ogilvie A.D., Smith C.A., Blackwood D.H., Muir W.J., Quinn J.P., et al. Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatr Genet 1996, 6(4):177-181.
32. Iga J., Ueno S., Yamauchi K., Numata S., Tayoshi-Shibuya S., Kinouchi S., et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:1003-1006.
33. Katerberg H., Lochner C., Cath D.C., de Jonge P., Bochdanovits Z., Moolman-Smook J.C., et al. The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD). Am J Med Genet B Neuropsychiatr Genet 2009, 150B:1050-1062.
34. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., Kennedy J.L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002, 71:651-655.
35. Lang U.E., Hellweg R., Kalus P., Bajbouj M., Lenzen K.P., Sander T., et al. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 2005, 180:95-99.
36. Bulgin N.L., Strauss J.S., King N.A., Shaikh S.A., George C.J., Fox N.A., et al. Association study of theta EEG asymmetry and brain-derived neurotrophic factor gene variants in childhood-onset mood disorder. Neuromolecular Med 2008, 10:343-355.
37. Lang U.E., Hellweg R., Sander T., Gallinat J. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry 2009, 14:120-122.